Skip to main content

Home/ Cheap Generic ED drugs/ Group items tagged treating

Rss Feed Group items tagged

Matilde Fernandes

Market Research Reports on Treating Refractory Hematological Malignancies - 0 views

  •  
    Treating refractory hematological malignancies unfold a host of competition and commercial opportunities. Approved therapies for AML, MDS, unmet need and limitations of the current SOC for relapsed and refractory pts attract swarming competition. There is severe competition amongst the companies to launch new therapies for this indication. Companies leading in the race to launch such therapies include Ambit Biosciences, Onconova Therapeutics, SymBio Pharma, and Celgene.
Matilde Fernandes

Global Fatty Liver Disease Trials Reviews - 1 views

  •  
    Elemental information and data relating to the clinical trials on fatty liver disease including an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe offers a perspective on the fatty liver disease clinical trial scenario. Disease clinical trials by their phase, trial status, prominence of the sponsors pertaining to the number of trials for the key drugs for treating fatty liver disease hints at the dynamics of a particular indication in a condensed manner in addition to the commercial landscape of the major universities, institutes, hospitals or companies.
Matilde Fernandes

Therapeutic Class Report Overview of Hepatitis C Virus Infection - 2 views

  •  
    The launch of Protease Inhibitors (PIs) accelerated the pace of innovation and impressive Sustained Virologic Response (SVR) rates by oral IFN free drug combinations. Freedom from IFN, treating all genotypes and vaccines could bring a sea of change in the HCV therapy class area in the future. Roche set the trend with the acquisition of Anadys for total of USD 230 mn followed by GILD buying VRUS for USD 11 bn, Bristol-Myers Squibb (BMY) acquiring Inhibitex for USD 2.5 bn, VRTX acquiring Virochem in 2009 for USD 375 mn, In-licensed Alios VX-135 in 2012 for total of USD 775 mn and Abbott in-licensed Enantas ABT-450 for total of USD 310 mn.
Matilde Fernandes

Global Research Report on Parkinson's Disease Market - 1 views

  •  
    One of the main drivers propelling the growth of the market for drugs used to treat patients with Parkinson's disease is the steadily growing aging population worldwide. This is because the number of patients suffering from Parkinson's disease is increasing owing to the rise in aging population both in the developing as well as developed nations. One of the major challenges to market growth is the weak pipeline landscape. Most products in the pipeline lack molecules that can potentially achieve blockbuster status in the near future.
Matilde Fernandes

Research on microbes super bugs signifies adoption - 2 views

  •  
    Novel approaches to treat infection is growing as the need is urgent. Misuse or overuse of antibiotics accelerated Anti-Microbial Resistance (AMR) and has resulted in the emergence of super bugs which are posing life threatening challenges worldwide. Novel approaches are immediately required to combat these super infections warranting need for new classes of antibiotics and other preventive/therapeutic approaches.
Matilde Fernandes

Fildena - 3 views

  •  
    Fildena 100 a well-known pill full of energy with S ildenafil Citrate as its active compound treats ED in men. The medicine serves as best technique to manage repeated penile failures. The formulation of this medicine guarantees to serve rock hard erection with toughness for longer hours.
  •  
    Thanks for the info! What other medications can be used? And can ED be cured?
  •  
    If you have the right diagnosis and go through the right treatment, erectile dysfunction can go away even without ED pills. Of course, there is a wide choice of such meds. For example, you can Buy viagra online https://www.canadadrugsdirect.com/products/viagra Though I recommend beginning by changing your daily routine, monitoring your nutrition and avoiding stress.
Matilde Fernandes

Global Clinical Trials Review on Abdominal Obesity - 3 views

  •  
    This report includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Obesity.
  •  
    Interesting info. What other meds can be taken?
  •  
    As far as I know, Xenical (Orlistat) promotes weight loss by decreasing the amount of dietary fat absorbed in your intestines. You can find out more about it on the Canada Drugs site https://www.canadadrugsdirect.com/. It has to be noted, that this medication should only be used under the supervision of a trained healthcare professional.
sophiachole

Fildena Purple Pill : An answer to prayer for men struggling with erectile dysfunction - 1 views

Fildena 100 Purple Pill is a strong medicine prestigious for its viability in treating erectile brokenness (ED) in men. Every pill contains 100mg of sildenafil citrate, a strong dynamic fixing that...

hralth

started by sophiachole on 16 May 24 no follow-up yet
1 - 8 of 8
Showing 20 items per page